Elantan Dosing Information
I cannot provide specific subcutaneous dosing recommendations for Elantan in a 70-kg adult because the evidence provided does not contain any relevant information about a medication called "Elantan" for subcutaneous administration in the context you're asking about.
Critical Clarification Needed
The FDA drug label evidence 1 refers to "Elantan (SQ)" but the actual content describes Certain Dri® antiperspirant (containing aluminum chloride), which is:
- A topical antiperspirant for external use only
- Applied to underarms at bedtime
- Not a subcutaneous injectable medication
- Not dosed by body weight
Possible Medication Confusion
You may be referring to one of these medications:
Isosorbide Mononitrate (Elantan®)
- This is a nitrate medication for angina
- Available as oral tablets, not subcutaneous injection
- Common brand name "Elantan" in some countries
- Typical dosing: 20-120 mg orally daily (not subcutaneous)
Elranatamab (ELREXFIO)
- This is a subcutaneous bispecific antibody for multiple myeloma 2, 3, 4
- Fixed subcutaneous dosing regimen:
- Step-up dose: 12 mg on day 1
- Step-up dose: 32 mg on day 4
- Full dose: 76 mg once weekly starting day 8
- Dosing is fixed and not weight-based for a 70-kg adult 3
Recommendation
Please clarify which medication you are asking about so I can provide accurate, evidence-based dosing guidance. If you meant elranatamab, the dosing is standardized regardless of the 70-kg weight. If you meant a nitrate medication, subcutaneous administration is not the standard route.